Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynastat for Postoperative Sore Throat Prevention
NCT03915561Phase 2Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative sore throat (POST) comparing Dynastat Group with Placebo Group (2 arms). Primary endpoints: Early incidence of Postoperative Sore Throat and Late incidence of Postoperative Sore Throat. Status: unknown.
02
Drugs
parecoxib
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT03915561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915561.